Multiple

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple…

More recently, the Heritage Foundation included a whole chapter on the Fed written by a former member of Trump’s 2016 transition team in its Project 2025 (a proposed blueprint for…